Fremont, NENCT07527650Now EnrollingIRB Ready

Type 2 Diabetes Mellitus Clinical Trial in Fremont, NE

Access cutting-edge type 2 diabetes mellitus treatment through this clinical trial at a research site in Fremont. Study-provided care at no cost to qualified participants.

Sponsored by Hanmi Pharmaceutical Company Limited

Quick Self-Assessment

See if you qualify for this Fremont location

Preparing your pre-screening questions…

Expert Care in Fremont

Access type 2 diabetes mellitus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 2 diabetes mellitus treatment provided free

Apply for This Fremont Location

Check if you qualify for this type 2 diabetes mellitus clinical trial in Fremont, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fremont

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fremont site if eligible
  4. 4Begin participation

About This Type 2 Diabetes Mellitus Study in Fremont

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.

Sponsor: Hanmi Pharmaceutical Company Limited

Who Can Participate

Inclusion Criteria

Participant's age at the time of signing the informed consent:
United States: 18 to 75 years (inclusive)
Diagnosed with type 2 diabetes mellitus (T2DM) with HbA1c ≥7.0% and ≤10.0% at screening
Treated with diet and exercise alone or on a stable dose of metformin (≥1000 mg/day) for at least 3 months prior to screening
BMI ≥25 kg/m² and ≤50 kg/m²
Body weight change \<5% over the past 3 months prior to screening
Capable of giving signed informed consent and willing to comply with all protocol procedures Key

Exclusion Criteria

Type 1 diabetes mellitus or use of glucose-lowering medications other than metformin within 3 months prior to screening
Poor glycemic control (fasting plasma glucose \>270 mg/dL)
History of diabetic ketoacidosis or severe hypoglycemia within 6 months
Clinically significant cardiovascular disease (e.g., NYHA class III/IV heart failure, recent myocardial infarction, stroke, or revascularization within 3 months)
History of pancreatitis or factors increasing the risk of pancreatitis
Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2
Clinically significant liver disease, renal impairment (eGFR \<60 mL/min/1.73 m²), or abnormal laboratory findings at screening
Participation in another investigational study within 30 days or within 5 half-lives of the investigational product, whichever is longer; for GLP-1 receptor agonist-related or weight loss studies, participation within 3 months prior to screening

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fremont?

Yes, this clinical trial (NCT07527650) has an active research site in Fremont, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 2 Diabetes Mellitus Treatment Options in Fremont, NE

If you're searching for type 2 diabetes mellitus treatment options in Fremont, NE, this clinical trial (NCT07527650) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fremont research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes mellitus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 2 diabetes mellitus clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Fremont, NE

See all pulmonary embolism clinical trials recruiting in Fremont — not just this study.

Browse Pulmonary Embolism Trials in Fremont →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Fremont?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fremont, NE